Cargando…
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
BACKGROUND: The COVID-19 pandemic, caused by a novel coronavirus termed SARS-CoV-2, has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following recovery from COVID-19 infection and development of antibodies against the virus is an attractive option for either prophylactic...
Autores principales: | Peng, Henry T, Rhind, Shawn G, Beckett, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245055/ https://www.ncbi.nlm.nih.gov/pubmed/33825689 http://dx.doi.org/10.2196/25500 |
Ejemplares similares
-
Correction: Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
por: Peng, Henry T, et al.
Publicado: (2021) -
Convalescent Plasma in the Treatment of Severe COVID-19: A Systematic Review and Meta-Analysis
por: ZHANG, Xuanguo, et al.
Publicado: (2020) -
Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis
por: Jorda, Anselm, et al.
Publicado: (2022) -
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2021) -
Convalescent plasma may be a possible treatment for COVID-19: A systematic review
por: Wang, Ying, et al.
Publicado: (2021)